D R Edwards, G Murphy. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AngiostatinsAnimalsAntineoplastic Agents/therapeutic useCathepsins/metabolismEndopeptidases/physiologyHumansMetalloendopeptidases/antagonists & inhibitorsMetalloendopeptidases/metabolismNeoplasms/blood supplyNeoplasms/drug therapyNeoplasms/enzymologyNeovascularization, Pathologic/drug therapyPeptide Fragments/therapeutic usePlasminogen/metabolismPlasminogen/therapeutic useProtease Inhibitors/therapeutic useReceptors, Cell Surface/metabolismReceptors, Urokinase Plasminogen ActivatorStromal Cells/enzymologyUrokinase-Type Plasminogen Activator/metabolism
Substances: See more » Antineoplastic AgentsPLAUR protein, humanPeptide FragmentsProtease InhibitorsReceptors, Cell SurfaceReceptors, Urokinase Plasminogen ActivatorAngiostatinsPlasminogenCathepsinsEndopeptidasesUrokinase-Type Plasminogen ActivatorMetalloendopeptidases
Year: 1998 PMID: 9707109 DOI: 10.1038/28961
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962